Pomalyst is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Celgene Corporation. The primary component is Pomalidomide.
| Product ID | 59572-502_0e50dfc9-35ac-4b11-89f1-5c3653717c3d | 
| NDC | 59572-502 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | Pomalyst | 
| Generic Name | Pomalidomide | 
| Dosage Form | Capsule | 
| Route of Administration | ORAL | 
| Marketing Start Date | 2013-02-18 | 
| Marketing Category | NDA / NDA | 
| Application Number | NDA204026 | 
| Labeler Name | Celgene Corporation | 
| Substance Name | POMALIDOMIDE | 
| Active Ingredient Strength | 2 mg/1 | 
| Pharm Classes | Thalidomide Analog [EPC] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2023-12-31 | 
| Marketing Start Date | 2013-02-18 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | NDA | 
| Application Number | NDA204026 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2013-02-18 | 
| Marketing Category | NDA | 
| Application Number | NDA204026 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2013-02-18 | 
| Ingredient | Strength | 
|---|---|
| POMALIDOMIDE | 2 mg/1 | 
| SPL SET ID: | 2b25ef01-5c9e-11e1-b86c-0800200c9a66 | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 59572-501 | Pomalyst | pomalidomide | 
| 59572-502 | Pomalyst | pomalidomide | 
| 59572-503 | Pomalyst | pomalidomide | 
| 59572-504 | Pomalyst | pomalidomide | 
Mark Image Registration | Serial  | Company  Trademark Application Date  | 
|---|---|
![]() POMALYST  85885565  4388257 Live/Registered  | 
        Celgene Corporation  2013-03-25  | 
![]() POMALYST  85150878  3980998 Live/Registered  | 
        Celgene Corporation  2010-10-12  |